{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:40:44Z","timestamp":1791294044238,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1059660"],"award-info":[{"award-number":["APP1059660"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1156072"],"award-info":[{"award-number":["APP1156072"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jad.2020.07.109","type":"journal-article","created":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T21:17:21Z","timestamp":1595279841000},"page":"970-983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["The concept and management of acute episodes of treatment-resistant bipolar disorder: a systematic review and exploratory meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"276","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9647-0853","authenticated-orcid":false,"given":"Michele","family":"Fornaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 F.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Anastasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Solmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0548-0053","authenticated-orcid":false,"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"de Bartolomeis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2020.07.109_bib0001","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1600-0447.2009.01493.x","article-title":"Electroconvulsive therapy is equally effective in unipolar and bipolar depression","volume":"121","author":"Bailine","year":"2010","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2020.07.109_bib0002","series-title":"Neuroprogression in Psychiatric Disorders","first-page":"10","article-title":"The link between refractoriness and neuroprogression in treatment-resistant bipolar disorder","author":"Bauer","year":"2017"},{"key":"10.1016\/j.jad.2020.07.109_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/0028-3908(78)90022-9","article-title":"The mania rating scale: scale construction and inter-observer agreement","author":"Bech","year":"1978","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.jad.2020.07.109_bib0004","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/j.jad.2020.07.109_bib0005","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1399-5618.2007.00484.x","article-title":"Setting the stage: from prodrome to treatment resistance in bipolar disorder","volume":"9","author":"Berk","year":"2007","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2020.07.109_bib0006","series-title":"Comprehensive Meta-Analysis Version 2","author":"Borenstein","year":"2005"},{"key":"10.1016\/j.jad.2020.07.109_bib0007","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4088\/JCP.11m07299","article-title":"A placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction","volume":"73","author":"Burdick","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.109_bib0008","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.4088\/JCP.09m05900gry","article-title":"Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double-blind, placebo-controlled, proof-of-concept study","volume":"71","author":"Calabrese","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.109_bib0009","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3389\/fnbeh.2014.00189","article-title":"A neurobiological hypothesis of treatment-resistant depression-mechanisms for selective serotonin reuptake inhibitor non-efficacy","volume":"8","author":"Coplan","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.jad.2020.07.109_bib0010","doi-asserted-by":"crossref","first-page":"963","DOI":"10.4088\/JCP.v63n1102","article-title":"The impact of treatment-resistant depression on health care utilization and costs","volume":"63","author":"Crown","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.109_bib0011","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pnpbp.2015.09.005","article-title":"Refractory bipolar disorder and neuroprogression","volume":"70","author":"da Costa","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.109_bib0012","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1034\/j.1399-5618.2001.030208.x","article-title":"ECT in bipolar and unipolar depression: differences in speed of response","volume":"3","author":"Daly","year":"2001","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2020.07.109_bib0013","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","article-title":"A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.109_bib0014","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1399-5618.2012.00997.x","article-title":"Efficacy of electroconvulsive therapy in bipolar versus unipolar major depression: a meta\u2010analysis","volume":"14","author":"Dierckx","year":"2012","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2020.07.109_bib0015","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.clinthera.2017.01.010","article-title":"A review of the theoretical and biological understanding of the nocebo and placebo phenomena","volume":"39","author":"Dodd","year":"2017","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jad.2020.07.109_bib0016","article-title":"Incidence and characteristics of the nocebo response from meta\u2010analyses of the placebo arms of clinical trials of olanzapine for bipolar disorder","author":"Dodd","year":"2018","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2020.07.109_bib0017","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1399-5618.2006.00243.x","article-title":"A double-blind, placebo-controlled trial of adjunctive donepezil in treatment-resistant mania","volume":"8","author":"Eden Evins","year":"2006","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2020.07.109_bib0018","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2020.07.109_bib0019","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1176\/appi.ajp.2015.15060788","article-title":"Clinical experience with high-dosage pramipexole in patients with treatment-resistant depressive episodes in unipolar and bipolar depression","volume":"173","author":"Fawcett","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.109_bib0020","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1192\/bjp.bp.111.102665","article-title":"Prediction of longer-term outcome of treatment-resistant depression in tertiary care","volume":"201","author":"Fekadu","year":"2012","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.109_bib0021","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4088\/JCP.08m04309","article-title":"A multidimensional tool to quantify treatment resistance in depression: the Maudsley staging method","volume":"70","author":"Fekadu","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.109_bib0022","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jad.2016.03.052","article-title":"A negative double-blind controlled trial of sequential bilateral rTMS in the treatment of bipolar depression","volume":"198","author":"Fitzgerald","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2020.07.109_bib0023","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/bdi.12612","article-title":"Incidence, prevalence and clinical correlates of antidepressant\u2010emergent mania in bipolar depression: a systematic review and meta\u2010analysis","volume":"20","author":"Fornaro","year":"2018","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2020.07.109_bib0024","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2147\/NDT.S100846","article-title":"Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review","volume":"12","author":"Fornaro","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2020.07.109_bib0025","first-page":"180","article-title":"The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for Bipolar disorder in adults (CINP-BD-2017), part 3: the clinical guidelines","volume":"20","author":"Fountoulakis","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2020.07.109_bib0026","article-title":"The CINP guidelines on the definition and the evidence-based interventions for treatment-resistant Bipolar disorder","author":"Fountoulakis","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2020.07.109_bib0027","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1176\/appi.ajp.2007.06060981","article-title":"A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression","volume":"164","author":"Frye","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.109_bib0028","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00004714-200012000-00004","article-title":"A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders","volume":"20","author":"Frye","year":"2000","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2020.07.109_bib0029","article-title":"Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis","volume":"6","author":"Furukawa","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2020.07.109_bib0030","doi-asserted-by":"crossref","unstructured":"Gaynes, B.N., Asher, G., Gartlehner, G., Hoffman, V., Green, J., Boland, E., Lux, L., Weber, R.P., Randolph, C., Bann, C., 2018. Definition of treatment-resistant depression in the Medicare population.","DOI":"10.1002\/da.22968"},{"key":"10.1016\/j.jad.2020.07.109_bib0031","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1192\/bjp.bp.107.048504","article-title":"Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials","volume":"194","author":"Geddes","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.109_bib0032","first-page":"227","article-title":"Treatment-resistant bipolar disorder","volume":"11","author":"Gitlin","year":"2007","journal-title":"Focus"},{"key":"10.1016\/j.jad.2020.07.109_bib0033","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1176\/appi.ajp.161.3.564","article-title":"Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression","volume":"161","author":"Goldberg","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.109_bib0034","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.psychres.2008.06.047","article-title":"Long-term efficacy of a psychological intervention program for patients with refractory bipolar disorder: a pilot study","volume":"176","author":"Gonz\u00e1lez-Isasi","year":"2010","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2020.07.109_bib0035","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/0269881103017002003","article-title":"Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology","volume":"17","author":"Goodwin","year":"2003","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2020.07.109_bib0036","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/15622970902823202","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania","volume":"10","author":"Grunze","year":"2009","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.109_bib0037","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.109_bib0038","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1192\/bjp.2018.257","article-title":"Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definition","volume":"214","author":"Hidalgo-Mazzei","year":"2019","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.109_bib0039","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2020.07.109_bib0040","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2020.07.109_bib0041","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jad.2014.04.020","article-title":"Rapid clozapine titration in treatment-refractory bipolar disorder","volume":"166","author":"Ifteni","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2020.07.109_bib0042","doi-asserted-by":"crossref","DOI":"10.1111\/bdi.12902","article-title":"The Korean Medication Algorithm Project for Bipolar Disorder (KMAP-BP): Changes in preferred treatment strategies and medications over 16 years and five editions","author":"Jon","year":"2020","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2020.07.109_bib0043","doi-asserted-by":"crossref","first-page":"g5673","DOI":"10.1136\/bmj.g5673","article-title":"Assessment and management of bipolar disorder: summary of updated NICE guidance","volume":"349","author":"Kendall","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2020.07.109_bib0044","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1471-244X-13-105","article-title":"Neurocognitive profiles in treatment-resistant bipolar I and bipolar II disorder depression","volume":"13","author":"Kessler","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2020.07.109_bib0045","doi-asserted-by":"crossref","first-page":"e1306","DOI":"10.4088\/JCP.13m08960","article-title":"The effect of electroconvulsive therapy on neurocognitive function in treatment-resistant bipolar disorder depression","volume":"75","author":"Kessler","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.109_bib0046","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.psychres.2018.09.008","article-title":"Drug-induced gambling disorder: a not so rare but underreported condition","volume":"269","author":"Lanteri","year":"2018","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2020.07.109_bib0047","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1192\/bjp.bp.110.086983","article-title":"Association between antidepressant resistance in unipolar depression and subsequent bipolar disorder: cohort study","volume":"200","author":"Li","year":"2012","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.109_bib0048","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1177\/0004867415617657","article-title":"Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders","volume":"49","author":"Malhi","year":"2015","journal-title":"Aust. N. Zeal. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.109_bib0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1192\/bjp.2018.246","article-title":"Treatment-resistant depression: problematic illness or a problem in our approach?","volume":"214","author":"Malhi","year":"2019","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.109_bib0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jad.2009.01.014","article-title":"Response to ECT in bipolar I, bipolar II and unipolar depression","volume":"118","author":"Medda","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2020.07.109_bib0051","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1177\/0706743716660033","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 4. Neurostimulation treatments","volume":"61","author":"Milev","year":"2016","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.109_bib0052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst. Rev."},{"key":"10.1016\/j.jad.2020.07.109_bib0053","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.109_bib0054","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/JCP.0000000000000064","article-title":"Oral SAMe in persistent treatment-refractory bipolar depression: a double-blind, randomized clinical trial","volume":"34","author":"Murphy","year":"2014","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2020.07.109_bib0055","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1600-0447.2009.01471.x","article-title":"Treatment\u2010resistant bipolar depression: towards a new definition","volume":"120","author":"Pacchiarotti","year":"2009","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2020.07.109_bib0056","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/NMD.0000000000000517","article-title":"Clinical characteristics associated with treatment-resistant bipolar disorder","volume":"205","author":"Parker","year":"2017","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.jad.2020.07.109_bib0057","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1176\/appi.ajp.163.2.217","article-title":"Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)","volume":"163","author":"Perlis","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.109_bib0058","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2174\/1570159X14666161017233642","article-title":"The role of electroconvulsive therapy (ECT) in bipolar disorder: effectiveness in 522 patients with bipolar depression, mixed-state, mania and catatonic features","volume":"15","author":"Perugi","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jad.2020.07.109_bib0059","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1399-5618.2012.01042.x","article-title":"Evidence\u2010based options for treatment\u2010resistant adult bipolar disorder patients","volume":"14","author":"Poon","year":"2012","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2020.07.109_bib0060","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1017\/S0033291700035558","article-title":"The inventory of depressive symptomatology (IDS): psychometric properties","volume":"26","author":"Rush","year":"1996","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2020.07.109_bib0061","first-page":"215","article-title":"Treatment-resistant bipolar depression","volume":"19","author":"Sachs","year":"1996","journal-title":"Psychiatr. Clin."},{"key":"10.1016\/j.jad.2020.07.109_bib0062","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1176\/appi.ajp.2014.13111517","article-title":"Treatment-resistant bipolar depression: a randomized controlled trial of electroconvulsive therapy versus algorithm-based pharmacological treatment","volume":"172","author":"Schoeyen","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.109_bib0063","series-title":"Antidepressants for the Acute Treatment of Bipolar Depression: a Systematic Review and Meta-analysis, Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet]","author":"Sidor","year":"2011"},{"key":"10.1016\/j.jad.2020.07.109_bib0064","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/bdi.12026","article-title":"Evidence\u2010based treatment strategies for treatment\u2010resistant bipolar depression: a systematic review","volume":"15","author":"Sienaert","year":"2013","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2020.07.109_bib0065","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1399-5618.2009.00702.x","article-title":"Ultra\u2010brief pulse ECT in bipolar and unipolar depressive disorder: differences in speed of response","volume":"11","author":"Sienaert","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2020.07.109_bib0066","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4088\/JCP.v66n0710","article-title":"The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder","volume":"66","author":"Suppes","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.109_bib0067","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1399-5618.2009.00726.x","article-title":"The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders","volume":"11","author":"Tohen","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2020.07.109_bib0068","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11920-013-0431-y","article-title":"Options for pharmacological treatment of refractory bipolar depression","volume":"16","author":"Tondo","year":"2014","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.jad.2020.07.109_bib0069","doi-asserted-by":"crossref","first-page":"18008","DOI":"10.1038\/nrdp.2018.8","article-title":"Bipolar disorders","volume":"4","author":"Vieta","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jad.2020.07.109_bib0070","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/bdi.12062","article-title":"A double-blind, placebo-controlled study of adjunctive calcitonin nasal spray in acute refractory mania","volume":"15","author":"Vik","year":"2013","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2020.07.109_bib0071","doi-asserted-by":"crossref","first-page":"434","DOI":"10.9758\/cpn.2018.16.4.434","article-title":"Korean medication algorithm project for bipolar disorder 2018 (KMAP-BP 2018): fourth revision","volume":"16","author":"Woo","year":"2018","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.jad.2020.07.109_bib0072","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1034\/j.1399-5618.2003.00019.x","article-title":"Bipolar depression: criteria for treatment selection, definition of refractoriness, and treatment options","volume":"5","author":"Yatham","year":"2003","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2020.07.109_bib0073","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bdi.12609","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2020.07.109_bib0074","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.109_bib0075","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","article-title":"Replication of ketamine\u2019s antidepressant efficacy in bipolar depression: a randomized controlled add-on trial","volume":"71","author":"Zarate","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.109_bib0076","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.biopsych.2004.03.013","article-title":"Pramipexole for bipolar II depression: a placebo-controlled proof of concept study","volume":"56","author":"Zarate","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.109_bib0077","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/da.22340","article-title":"Pioglitazone adjunctive therapy for depressive episode of bipolar disorder: a randomized, double\u2010blind, placebo\u2010controlled trial","volume":"32","author":"Zeinoddini","year":"2015","journal-title":"Depress. Anxiety"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032720325544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032720325544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:57:26Z","timestamp":1759024646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032720325544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":77,"alternative-id":["S0165032720325544"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2020.07.109","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The concept and management of acute episodes of treatment-resistant bipolar disorder: a systematic review and exploratory meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2020.07.109","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}